GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Allied Healthcare Products Inc (OTCPK:AHPIQ) » Definitions » Intrinsic Value: Projected FCF

Allied Healthcare Products (Allied Healthcare Products) Intrinsic Value: Projected FCF : $0.00 (As of Apr. 29, 2024)


View and export this data going back to 1992. Start your Free Trial

What is Allied Healthcare Products Intrinsic Value: Projected FCF?

Since the intrinsic value calculations based on Discounted Cash Flow Intrinsic Value: DCF (FCF Based), or Discounted Earnings Intrinsic Value: DCF (Earnings Based) cannot be applied to companies without consistent revenue and earnings, GuruFocus developed a valuation model based on normalized Free Cash Flow and Book Value of the company. The details of how we calculate the intrinsic value of stocks are described in detail here.

As of today (2024-04-29), Allied Healthcare Products's Intrinsic Value: Projected FCF is $0.00. The stock price of Allied Healthcare Products is $0.0001. Therefore, Allied Healthcare Products's Price-to-Intrinsic-Value-Projected-FCF of today is 0.0.

The historical rank and industry rank for Allied Healthcare Products's Intrinsic Value: Projected FCF or its related term are showing as below:

AHPIQ's Price-to-Projected-FCF is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 1.67
* Ranked among companies with meaningful Price-to-Projected-FCF only.

Allied Healthcare Products Intrinsic Value: Projected FCF Historical Data

The historical data trend for Allied Healthcare Products's Intrinsic Value: Projected FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Allied Healthcare Products Intrinsic Value: Projected FCF Chart

Allied Healthcare Products Annual Data
Trend Jun13 Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22
Intrinsic Value: Projected FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.52 0.80 1.28 - -2.58

Allied Healthcare Products Quarterly Data
Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22
Intrinsic Value: Projected FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - -0.54 -1.18 -1.15 -2.58

Competitive Comparison of Allied Healthcare Products's Intrinsic Value: Projected FCF

For the Medical Devices subindustry, Allied Healthcare Products's Price-to-Projected-FCF, along with its competitors' market caps and Price-to-Projected-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Allied Healthcare Products's Price-to-Projected-FCF Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Allied Healthcare Products's Price-to-Projected-FCF distribution charts can be found below:

* The bar in red indicates where Allied Healthcare Products's Price-to-Projected-FCF falls into.



Allied Healthcare Products Intrinsic Value: Projected FCF Calculation

Since the intrinsic value calculations based on Discounted Cash Flow Intrinsic Value: DCF (FCF Based), or Discounted Earnings Intrinsic Value: DCF (Earnings Based) cannot be applied to companies without consistent revenue and earnings, GuruFocus developed a valuation model based on normalized Free Cash Flow and Book Value of the company.

The details of how we calculate the intrinsic value of stocks are described in detail here.

This method smooths out the free cash flow over the past 6-7 years, multiplies the results by a growth multiple, and adds a portion of Total Stockholders Equity.

Intrinsic Value: Projected FCF = ( Growth Multiple * Free Cash Flow (6 year avg) + 0.8 * Total Stockholders Equity (most recent) ) / Shares Outstanding (Diluted Average)

In the case of negative Total Stockholders Equity, the following formula is used (see Explanation section below for the reason):

Intrinsic Value: Projected FCF = ( Growth Multiple * Free Cash Flow (6 year avg) + Total Stockholders Equity (most recent) / 0.8 ) / Shares Outstanding (Diluted Average)


Add all the Free Cash Flow together and divide 6 will get Allied Healthcare Products's Free Cash Flow(6 year avg) = $-1.53.

Allied Healthcare Products's Intrinsic Value: Projected FCF for today is calculated as

Intrinsic Value: Projected FCF=(Growth Multiple*Free Cash Flow (6 year avg)+Total Stockholders Equity (Jun22)*0.8)/Shares Outstanding (Diluted Average)
=(9.5203515959648*-1.5288+5.234*0.8)/4.014
=-2.58

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Allied Healthcare Products  (OTCPK:AHPIQ) Intrinsic Value: Projected FCF Explanation

The growth multiple is capped between 8.35 and 17.74.

Total Stockholders Equity weighting is more art than science and it should always be revisited in more detail when researching a company. Weightings from 0% to 100% to more than 100% are possible. 80% was chosen as a happy median after taking the above ideas into consideration.

Allied Healthcare Products's Price-to-Intrinsic-Value-Projected-FCF for today is calculated as

Price-to-Intrinsic-Value-Projected-FCF=Share Price/Intrinsic Value: Projected FCF
=0.0001/-2.5828384454188
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Allied Healthcare Products Intrinsic Value: Projected FCF Related Terms

Thank you for viewing the detailed overview of Allied Healthcare Products's Intrinsic Value: Projected FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Allied Healthcare Products (Allied Healthcare Products) Business Description

Traded in Other Exchanges
N/A
Address
1720 Sublette Avenue, Saint Louis, MO, USA, 63110
Allied Healthcare Products Inc manufactures a variety of respiratory products used in the healthcare industry in a wide range of hospital and alternate site settings, including sub-acute care facilities, home health care, and emergency medical care. The product line of the company includes respiratory anesthesia products, home respiratory care products, medical gas system construction products, medical gas system regulation devices, disposable oxygen, and specialty gas cylinders, portable suction equipment, trauma, and patient handling products, respiratory products, and others. The company markets its products under various brand names Timeter, Carbolime, Litholyme, Schuco, Chemetron, Oxequip, Lif-O-Gen, Gomco, and others.
Executives
John D Weil director, 10 percent owner 10 S. BROADWAY, SUITE 2000, ST LOUIS MO 63102
Susan M Deuser director 1720 SUBLETTE AVENUE, ST. LOUIS MO 63110
Kevin D Kroupa officer: Vice President of Operations 1720 SUBLETTE AVENUE, ST. LOUIS MO 63110
Earl R Refsland director, officer: President and CEO 1720 SUBLETT AVENUE, ST. LOUIS MO 63110
Joseph F Ondrus officer: Vice President of Operations 1720 SUBLETTE AVENUE, ST. LOUIS MO 63110
Andrew Riley officer: VP of Operations 1720 SUBLETTE AVE., ST. LOUIS MO 63110
William A Peck director 35 CROSBY DRIVE, BEDFORD MA 01730
Daniel C Dunn officer: VP - Finance and CFO 1720 SUBLETTE AVE, ST. LOUIS MO 63110
Eldon P Rosentrater officer: VP - Administration 1720 SUBLETTE AVE, ST. LOUIS MO 63110
Root Joseph Ernest Jr director HAYNES BEFFEL & WOLFELD LLP, 751 KELLY STREET, HALF MOON BAY CA 94019
Robert Bradley Harris officer: Vice President of Operations 15 RIVER RIDGE TRAIL, ORMOND BEACH FL 32174
Judy T Graves director 13317 WESTERMAN RD, ST LOUIS MO 63122
Hickey James B Jr director 4608 EDINA BLVD, EDINA MN 55424
Richard A Setzer officer: VICE PRESIDENT SALES & MKTG 1720 SUBLETTE AVENUE, ST. LOUIS MO 63110
Brent D Baird director 1350 ONE M&T PLAZA, BUFFALO NY 14203-2396